Starsource Multitrade Ltd

As of 19-Nov, Starsource Multitrade Ltd's stock price is Rs 111.00, down 5.93%, underperforming its sector and trading below all moving averages, indicating a bearish trend. Despite a significant decline over the past week, investor participation has increased, suggesting some interest amid the downturn.

As of 18-Nov, Starsource Multitrade Ltd is currently priced at 118.00, reflecting a 5.26% increase after a trend reversal. Despite recent declines, today's gains and heightened investor participation suggest a potential recovery in sentiment.

As of 17-Nov, Starsource Multitrade Ltd's stock price is Rs 116.00, down 6.68%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with a significant drop in investor participation.

The historical performance of Starsource Multi for the year ending March 2016 was poor, with total operating income of 0.49 Cr, a loss before tax of -1.35 Cr, and a negative EPS of -9.66, indicating significant financial challenges. The company had total liabilities of 3.87 Cr against shareholder's funds of 3.67 Cr, reflecting a precarious financial position.

Starsource Multi faced significant financial challenges in the year ending March 2016, reporting an operating loss of -1.35 Cr, a negative EPS of -9.66, and a PAT margin of -294.51%. The company had total liabilities of 3.87 Cr against shareholder's funds of 3.67 Cr, indicating a difficult financial position.

The next results date for Starsource Multi is 13 November 2025.

As of 11-Nov, Starsource Multitrade Ltd is experiencing a price increase to 124.00, reflecting a rise of 7.36% and marking a reversal after five days of decline. Despite strong performance and a 47.62% annual return, a significant drop in delivery volume indicates cautious investor sentiment.

As of 07-Nov, Starsource Multitrade Ltd's stock price is declining at 115.70, down 1.99%, and has lost 11.58% over the past week. Despite positive year-to-date returns, its recent performance is significantly lagging behind the benchmark Sensex, indicating a bearish trend and challenging market conditions.

As of 03-Nov, Chemo Pharma Laboratories Ltd is priced at 130.00, down 0.65%. Despite a slight decline today, the stock has shown strong overall performance with an 18.35% year-to-date gain, outperforming the Sensex.

As of 31-Oct, Chemo Pharma Laboratories Ltd is currently priced at Rs 129.00, reflecting a 10.87% increase and strong performance compared to its sector. The stock shows positive trends with significant investor interest and resilience in a challenging market, evidenced by impressive returns both short-term and long-term.

As of 30-Oct, Chemo Pharma Laboratories Ltd's stock price is at 116.00, down 5.81%, underperforming its sector and showing bearish sentiment despite positive long-term returns. Recent trading patterns indicate volatility, with the stock lagging behind broader market trends.

As of 15-Oct, Chemo Pharma Laboratories Ltd's stock price is at 125.50, having increased slightly by 0.08%. Despite a strong year-to-date gain of 14.26% and a yearly increase of 71.00%, recent investor participation has declined significantly, indicating potential caution among traders.

As of 13-Oct, Chemo Pharma Laboratories Ltd's stock price is 115.00, down 4.29% after three consecutive days of decline totaling 14.72%. Despite strong year-to-date and annual performance, the stock has underperformed its sector and the broader market recently.

As of 09-Oct, Chemo Pharma Laboratories Ltd's stock price is at 125.00, down 7.3% after a volatile day. Despite strong year-to-date and annual returns, the current decline reflects negative investor sentiment and decreased participation.

As of 08-Oct, Chemo Pharma Laboratories Ltd is experiencing a price increase to Rs 134.70, up 10.68%, and has outperformed its sector significantly. Despite a recent drop in delivery volume, the stock shows strong long-term gains and positive investor sentiment compared to the broader market.

As of 07-Oct, Chemo Pharma Laboratories Ltd's stock price is Rs 121.00, down -6.67% after a recent decline. The stock has underperformed compared to the Sensex, with decreased trading volume and negative market sentiment contributing to its challenges.

As of 06-Oct, Chemo Pharma Laboratories Ltd's stock price has declined to Rs 126.00, down 4.55%, after two days of gains. Despite this short-term drop, the stock has shown strong long-term performance with a year-to-date increase of 14.71% and a 90.91% rise over the past year, indicating potential for recovery.

As of 30-Sep, Chemo Pharma Laboratories Ltd's stock price is Rs 114.00, down 6.48%, underperforming its sector and showing a bearish trend with significant selling pressure and reduced investor interest. Despite a year-to-date increase, recent declines indicate a troubling short-term outlook.

As of 29-Sep, Chemo Pharma Laboratories Ltd is experiencing a price increase to Rs 121.90, reflecting a rise of 6.93%. The stock has shown strong performance with a 76.64% increase over the past year and has outperformed its sector today, indicating rising investor interest.